Format

Send to

Choose Destination
Dermatol Clin. 2010 Jan;28(1):107-14. doi: 10.1016/j.det.2009.10.020.

Dystrophic epidermolysis bullosa: pathogenesis and clinical features.

Author information

1
Department of Dermatology, University Medical Center Freiburg, Hauptstrasse 7, 79104 Freiburg, Germany. bruckner-tuderman@uniklinik-freiburg.de

Abstract

Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.

PMID:
19945622
DOI:
10.1016/j.det.2009.10.020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center